Columbia neuroscientists have identified a genetic mutation that fends off Alzheimer's in people at high risk and could lead to a new way to protect people from the disease.
With funding from the Ultra-rare Gene-based Therapy Network, scientists at Columbia and the n-Lorem Foundation will create tailor-made gene-based therapies for people with rare forms of ALS.
A study led by Columbia and Cornell researchers finds, surprisingly, that anticoagulants do not prevent recurrent strokes in people with one type of heart condition.
Columbia researchers have taken a significant step forward toward deciphering the genetics of schizophrenia, which could have important implications for early detection of the condition.
A study of long-acting injectable antipsychotics for people with schizophrenia found that newer medication was no more effective than older, less expensive medication.